Company / Revenue per Share
Enovis Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$39.31
FY2025
5-year range
$12.04 / $39.31
FY2021-FY2025
Trend
+1.8%
vs FY2024
Sector context
#49 of 153
Health Care
What the data says
At $39.31, Enovis's revenue per share ranks #49 of 153 in the Health Care sector. Revenue per Share has increased for 4 consecutive years, from $12.04 in FY2021 to $39.31 in FY2025.
Based on SEC 10-K filings.
39.31 in FY2025 with a 5-year CAGR of +16.2%.
Improved from $26.30 to $39.31 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +22.2%
- 5-Year CAGR
- +16.2%
- 10-Year CAGR
- -
Sector benchmark
#49 of 153 in Health CareTop 32% of 153This company $39.31 Sector average $124.28
▼
-68.4% below sector average
Key checks
Key Insights
- Enovis's revenue per share has grown for 4 consecutive years.
- In FY2025, revenue per share increased 1.8% year-over-year.
- Ranks #49 out of 153 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $39.31 | +1.8% |
| FY2024 | $38.60 | +46.8% |
| FY2023 | $26.30 | +22.2% |
| FY2022 | $21.52 | +78.8% |
| FY2021 | $12.04 | -35.2% |
| FY2020 | $18.58 | +12.5% |
| FY2019 | $16.52 | -9.0% |
| FY2018 | $18.16 | -35.1% |
| FY2017 | $27.97 | +8.4% |
| FY2016 | $25.80 | -24.1% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026